Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 93.89% | 93.89% | -8.04% | -1,731.34% | -1,731.34% |
| Total Depreciation and Amortization | 4.65% | 4.65% | -5.66% | -3.49% | -3.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.33% | -13.33% | -80.22% | 3,534.19% | 3,534.19% |
| Change in Net Operating Assets | -459.05% | -459.05% | -512.75% | -113.21% | -113.21% |
| Cash from Operations | -7.59% | -7.59% | -92.18% | -150.63% | -150.63% |
| Capital Expenditure | 4.60% | 4.60% | -308.72% | -11,166.67% | -11,166.67% |
| Sale of Property, Plant, and Equipment | 200.00% | 200.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.12% | 62.12% | -- | -- | -- |
| Cash from Investing | 28.81% | 28.81% | -573.39% | -11,166.67% | -11,166.67% |
| Total Debt Issued | -19.32% | -19.32% | 6.56% | 122.39% | 122.39% |
| Total Debt Repaid | -104.78% | -104.78% | 44.15% | 3.19% | 3.19% |
| Issuance of Common Stock | -100.00% | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -123.93% | -123.93% | 903.28% | 191.58% | 191.58% |
| Foreign Exchange rate Adjustments | 581.74% | 581.74% | 125.29% | -98.41% | -98.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.30% | -166.30% | 369.08% | -50.62% | -50.62% |